Oxazole compound crystal
    1.
    发明授权

    公开(公告)号:US11840512B2

    公开(公告)日:2023-12-12

    申请号:US17859675

    申请日:2022-07-07

    IPC分类号: C07D263/32

    CPC分类号: C07D263/32 C07B2200/13

    摘要: Provided is a crystal of a specific oxazole compound that has specific inhibitory activity against PDE4, and that shows excellent stability. Specifically, provided is a crystal of an oxazole compound represented by formula (5)






    wherein the crystal has peaks at diffraction angles 2θ(°) of 9.6±0.2, 19.1±0.2, and 21.2±0.2 in an X-ray powder diffraction pattern measured using CuKα characteristic X-rays.

    Oxazole compound crystal
    2.
    发明授权

    公开(公告)号:US11414391B2

    公开(公告)日:2022-08-16

    申请号:US17044892

    申请日:2019-04-03

    IPC分类号: C07D263/32

    摘要: Provided is a crystal of a specific oxazole compound that has specific inhibitory activity against PDE4, and that shows excellent stability. Specifically, provided is a crystal of an oxazole compound represented by formula (5) wherein the crystal has peaks at diffraction angles 2θ(°) of 9.6±0.2, 19.1±0.2, and 21.2±0.2 in an X-ray powder diffraction pattern measured using CuKα characteristic X-rays.

    OXAZOLE COMPOUND CRYSTAL
    3.
    发明公开

    公开(公告)号:US20240076275A1

    公开(公告)日:2024-03-07

    申请号:US18498894

    申请日:2023-10-31

    IPC分类号: C07D263/32

    CPC分类号: C07D263/32 C07B2200/13

    摘要: Provided is a crystal of a specific oxazole compound that has specific inhibitory activity against PDE4, and that shows excellent stability. Specifically, provided is a crystal of an oxazole compound represented by formula (5)




    wherein the crystal has peaks at diffraction angles)2θ(°) of 9.6±0.2, 19.1±0.2, and 21.2±0.2 in an X-ray powder diffraction pattern measured using CuKα characteristic X-rays.

    OXAZOLE COMPOUND CRYSTAL
    4.
    发明申请

    公开(公告)号:US20220411386A1

    公开(公告)日:2022-12-29

    申请号:US17859675

    申请日:2022-07-07

    IPC分类号: C07D263/32

    摘要: Provided is a crystal of a specific oxazole compound that has specific inhibitory activity against PDE4, and that shows excellent stability. Specifically, provided is a crystal of an oxazole compound represented by formula (5) wherein the crystal has peaks at diffraction angles 2θ(°) of 9.6±0.2, 19.1±0.2, and 21.2±0.2 in an X-ray powder diffraction pattern measured using CuKα characteristic X-rays.